Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations.

George SL, Izquierdo E, Campbell J, Koutroumanidou E, Proszek P, Jamal S, Hughes D, Yuan L, Marshall LV, Carceller F, Chisholm JC, Vaidya S, Mandeville H, Angelini P, Wasti A, Bexelius T, Thway K, Gatz SA, Clarke M, Al-Lazikani B, Barone G, Anderson J, Tweddle DA, Gonzalez D, Walker BA, Barton J, Depani S, Eze J, Ahmed SW, Moreno L, Pearson A, Shipley J, Jones C, Hargrave D, Jacques TS, Hubank M, Chesler L.

Eur J Cancer. 2019 Sep 11. pii: S0959-8049(19)30446-0. doi: 10.1016/j.ejca.2019.07.027. [Epub ahead of print]

2.

Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy.

Romo-Morales A, Aladowicz E, Blagg J, Gatz SA, Shipley JM.

Pediatr Blood Cancer. 2019 Sep;66(9):e27888. doi: 10.1002/pbc.27888. Epub 2019 Jun 17.

PMID:
31207107
3.

Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours.

Izquierdo E, Yuan L, George S, Hubank M, Jones C, Proszek P, Shipley J, Gatz SA, Stinson C, Moore AS, Clifford SC, Hicks D, Lindsey JC, Hill RM, Jacques TS, Chalker J, Thway K, O'Connor S, Marshall L, Moreno L, Pearson A, Chesler L, Walker BA, De Castro DG.

Oncotarget. 2017 Dec 6;8(67):112036-112050. doi: 10.18632/oncotarget.23000. eCollection 2017 Dec 19.

4.

MCM3AP and POMP Mutations Cause a DNA-Repair and DNA-Damage-Signaling Defect in an Immunodeficient Child.

Gatz SA, Salles D, Jacobsen EM, Dörk T, Rausch T, Aydin S, Surowy H, Volcic M, Vogel W, Debatin KM, Stütz AM, Schwarz K, Pannicke U, Hess T, Korbel JO, Schulz AS, Schumacher J, Wiesmüller L.

Hum Mutat. 2016 Mar;37(3):257-68. doi: 10.1002/humu.22939. Epub 2015 Dec 30.

PMID:
26615982
5.

Less Can Be More for Gene Dose and Drug Sensitivity.

Gatz SA, Shipley JM.

Clin Cancer Res. 2015 Nov 1;21(21):4750-2. doi: 10.1158/1078-0432.CCR-15-1153. Epub 2015 Jul 21.

6.

Chemotherapy responsiveness in a patient with multiply relapsed ameloblastic fibro-odontosarcoma of the maxilla.

Gatz SA, Thway K, Mandeville H, Kerawala C, MacVicar D, Chisholm J.

Pediatr Blood Cancer. 2015 Nov;62(11):2029-32. doi: 10.1002/pbc.25627. Epub 2015 Jul 15.

7.

Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experience.

Morgenstern DA, Hargrave D, Marshall LV, Gatz SA, Barone G, Crowe T, Pritchard-Jones K, Zacharoulis S, Lancaster DL, Vaidya SJ, Chisholm JC, Pearson AD, Moreno L.

J Pediatr Hematol Oncol. 2014 Apr;36(3):218-23. doi: 10.1097/MPH.0000000000000003.

PMID:
24322496
8.

SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.

Schuetz C, Neven B, Dvorak CC, Leroy S, Ege MJ, Pannicke U, Schwarz K, Schulz AS, Hoenig M, Sparber-Sauer M, Gatz SA, Denzer C, Blanche S, Moshous D, Picard C, Horn BN, de Villartay JP, Cavazzana M, Debatin KM, Friedrich W, Fischer A, Cowan MJ.

Blood. 2014 Jan 9;123(2):281-9. doi: 10.1182/blood-2013-01-476432. Epub 2013 Oct 21. Erratum in: Blood. 2018 Dec 6;132(23):2527.

9.

A case of selective mutism in an 8-year-old girl with thalassaemia major after bone marrow transplantation.

Plener PL, Gatz SA, Schuetz C, Ludolph AG, Kölch M.

Pharmacopsychiatry. 2012 Jan;45(1):37-9. doi: 10.1055/s-0031-1287776. Epub 2011 Oct 11.

PMID:
21989599
10.

Requirement for DNA ligase IV during embryonic neuronal development.

Gatz SA, Ju L, Gruber R, Hoffmann E, Carr AM, Wang ZQ, Liu C, Jeggo PA.

J Neurosci. 2011 Jul 6;31(27):10088-100. doi: 10.1523/JNEUROSCI.1324-11.2011. Erratum in: J Neurosci. 2011 Sep 21;31(38):13695.

11.

Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases.

Schulz AS, Glatting G, Hoenig M, Schuetz C, Gatz SA, Grewendorf S, Sparber-Sauer M, Muche R, Blumstein N, Kropshofer G, Suttorp M, Bunjes D, Debatin KM, Reske SN, Friedrich W.

Blood. 2011 Apr 28;117(17):4642-50. doi: 10.1182/blood-2010-06-284349. Epub 2011 Feb 15.

PMID:
21325170
12.

Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation.

Gatz SA, Benninghoff U, Schütz C, Schulz A, Hönig M, Pannicke U, Holzmann KH, Schwarz K, Friedrich W.

Bone Marrow Transplant. 2011 Apr;46(4):552-6. doi: 10.1038/bmt.2010.169. Epub 2010 Jul 12.

PMID:
20622910
13.

Role of SIRT1 in homologous recombination.

Uhl M, Csernok A, Aydin S, Kreienberg R, Wiesmüller L, Gatz SA.

DNA Repair (Amst). 2010 Apr 4;9(4):383-93. doi: 10.1016/j.dnarep.2009.12.020. Epub 2010 Jan 25.

PMID:
20097625
14.

Multifocal osteomyelitis caused by Candida dubliniensis.

Wellinghausen N, Moericke A, Bundschuh S, Friedrich W, Schulz AS, Gatz SA.

J Med Microbiol. 2009 Mar;58(Pt 3):386-90. doi: 10.1099/jmm.0.003970-0.

PMID:
19208893
15.

Take a break--resveratrol in action on DNA.

Gatz SA, Wiesmüller L.

Carcinogenesis. 2008 Feb;29(2):321-32. doi: 10.1093/carcin/bgm276. Epub 2008 Jan 3.

PMID:
18174251
16.

Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53- and -Nbs1-dependent manner.

Gatz SA, Keimling M, Baumann C, Dörk T, Debatin KM, Fulda S, Wiesmüller L.

Carcinogenesis. 2008 Mar;29(3):519-27. doi: 10.1093/carcin/bgm283. Epub 2008 Jan 3.

PMID:
18174244
17.

p53 in recombination and repair.

Gatz SA, Wiesmüller L.

Cell Death Differ. 2006 Jun;13(6):1003-16. Review.

18.

A PCR-SSP method to specifically select HLA-A*0201 individuals for immunotherapeutic studies.

Gatz SA, Pohla H, Schendel DJ.

Tissue Antigens. 2000 Jun;55(6):532-47.

PMID:
10902609

Supplemental Content

Support Center